Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

138 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase I clinical trial of a ribozyme-based angiogenesis inhibitor targeting vascular endothelial growth factor receptor-1 for patients with refractory solid tumors.
Weng DE, Masci PA, Radka SF, Jackson TE, Weiss PA, Ganapathi R, Elson PJ, Capra WB, Parker VP, Lockridge JA, Cowens JW, Usman N, Borden EC. Weng DE, et al. Among authors: ganapathi r. Mol Cancer Ther. 2005 Jun;4(6):948-55. doi: 10.1158/1535-7163.MCT-04-0210. Mol Cancer Ther. 2005. PMID: 15956252 Clinical Trial.
Phase 1 trial of Anvirzel in patients with refractory solid tumors.
Mekhail T, Kaur H, Ganapathi R, Budd GT, Elson P, Bukowski RM. Mekhail T, et al. Among authors: ganapathi r. Invest New Drugs. 2006 Sep;24(5):423-7. doi: 10.1007/s10637-006-7772-x. Invest New Drugs. 2006. PMID: 16763787 Clinical Trial.
Association of VEGF and VEGFR2 single nucleotide polymorphisms with hypertension and clinical outcome in metastatic clear cell renal cell carcinoma patients treated with sunitinib.
Kim JJ, Vaziri SA, Rini BI, Elson P, Garcia JA, Wirka R, Dreicer R, Ganapathi MK, Ganapathi R. Kim JJ, et al. Among authors: ganapathi r, ganapathi mk. Cancer. 2012 Apr 1;118(7):1946-54. doi: 10.1002/cncr.26491. Epub 2011 Aug 31. Cancer. 2012. PMID: 21882181 Free PMC article.
Telomerase activity in stage II colorectal carcinoma.
Kawanishi-Tabata R, Lopez F, Fratantonio S, Kim N, Goldblum J, Tubbs R, Elson P, Lavery I, Bukowski RM, Ganapathi R, Ganapathi MK. Kawanishi-Tabata R, et al. Among authors: ganapathi r, ganapathi mk. Cancer. 2002 Nov 1;95(9):1834-9. doi: 10.1002/cncr.10911. Cancer. 2002. PMID: 12404275 Free article.
von Hippel-Lindau gene status and response to vascular endothelial growth factor targeted therapy for metastatic clear cell renal cell carcinoma.
Choueiri TK, Vaziri SA, Jaeger E, Elson P, Wood L, Bhalla IP, Small EJ, Weinberg V, Sein N, Simko J, Golshayan AR, Sercia L, Zhou M, Waldman FM, Rini BI, Bukowski RM, Ganapathi R. Choueiri TK, et al. Among authors: ganapathi r. J Urol. 2008 Sep;180(3):860-5; discussion 865-6. doi: 10.1016/j.juro.2008.05.015. Epub 2008 Jul 17. J Urol. 2008. PMID: 18635227
Renal cell carcinoma (RCC) and telomerase activity: relationship to stage.
Mekhail TM, Kawanishi-Tabata R, Tubbs R, Novick A, Elson P, Ganapathi R, Ganapathi M, Bukowski R. Mekhail TM, et al. Among authors: ganapathi m, ganapathi r. Urol Oncol. 2003 Nov-Dec;21(6):424-30. doi: 10.1016/s1078-1439(03)00003-6. Urol Oncol. 2003. PMID: 14693268
138 results